Marksans Pharma Limited
Kotak Mutual Fund's name has dropped from Marksans Pharma Limited's latest shareholder list. After previously holding a 1.14 percent stake, Kotak Mutual Fund has either fully exited the company or trimmed its position below the 1 percent disclosure threshold.
A pharmaceutical formulation company engaged in the development and manufacture of a diverse range of drugs across multiple therapeutic areas for domestic and international markets. Marksans Pharma produces generic medications and branded formulations with a focus on quality and regulatory compliance. The company operates modern manufacturing facilities designed to meet stringent pharmaceutical production standards and global quality requirements.
Wholly owned subsidiary of Kotak Mahindra Bank, one of India's leading private banks. Manages over Rs 4.5 lakh crore in AUM. MD Nilesh Shah is a fixture in Indian financial media and one of the most quoted fund managers in the country. Known for disciplined quality growth positioning and clear communication of investment rationale to investors.